Controlled delivery of peptides and proteins I Tuncer Degim, N Celebi Current pharmaceutical design 13 (1), 99-117, 2007 | 217 | 2007 |
Epidermal permeability–penetrant structure relationships: 4, QSAR of permeant diffusion across human stratum corneum in terms of molecular weight, H-bonding and electronic charge WJ Pugh, IT Degim, J Hadgraft International journal of pharmaceutics 197 (1-2), 203-211, 2000 | 129 | 2000 |
New tools and approaches for predicting skin permeability IT Degim Drug discovery today 11 (11-12), 517-523, 2006 | 101 | 2006 |
Prediction of skin penetration using artificial neural network (ANN) modeling T Değim, J Hadgraft, S İlbasmiş, Y Özkan Journal of pharmaceutical sciences 92 (3), 656-664, 2003 | 91 | 2003 |
Skin permeability data: anomalous results IT Degim, WJ Pugh, J Hadgraft International journal of pharmaceutics 170 (1), 129-133, 1998 | 88 | 1998 |
Anti-aging formulation of rosmarinic acid-loaded ethosomes and liposomes Ç Yücel, G Şeker Karatoprak, İT Değim Journal of microencapsulation 36 (2), 180-191, 2019 | 78 | 2019 |
Carbon nanotubes for transdermal drug delivery IT Degim, DJ Burgess, F Papadimitrakopoulos Journal of microencapsulation 27 (8), 669-681, 2010 | 76 | 2010 |
Carbon nanotubes to deliver drug molecules S Ilbasmiş-Tamer, Ş Yilmaz, E Banoğlu, IT Değim Journal of Biomedical Nanotechnology 6 (1), 20-27, 2010 | 75 | 2010 |
Rapid and simultaneous determination of acetylsalicylic acid, paracetamol, and their degradation and toxic impurity products by HPLC in pharmaceutical dosage forms C Akay, İT Değim, A Sayal, A Aydin, Y Özkan, H Gül Turkish Journal of Medical Sciences 38 (2), 167-173, 2008 | 72 | 2008 |
The effects of Azone and capsaicin on the permeation of naproxen through human skin IT Degim, A Uslu, J Hadgraft, T Atay, C Akay, S Cevheroglu International journal of pharmaceutics 179 (1), 21-25, 1999 | 68 | 1999 |
Reverse iontophoresis: a non-invasive technique for measuring blood urea level IT Degim, S Ilbasmis, R Dundaroz, Y Oguz Pediatric Nephrology 18, 1032-1037, 2003 | 64 | 2003 |
Oral montelukast treatment of preschool-aged children with acute asthma K Harmanci, A Bakirtas, I Turktas, T Degim Annals of Allergy, Asthma & Immunology 96 (5), 731-735, 2006 | 61 | 2006 |
Evaluation of neuroprotective and anti-fatigue effects of sildenafil S Uthayathas, SS Karuppagounder, SI Tamer, K Parameshwaran, ... Life sciences 81 (12), 988-992, 2007 | 55 | 2007 |
Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of celecoxib through human skin G Yener, Ü Gönüllü, M Üner, T Değim, A Araman Die Pharmazie-An International Journal of Pharmaceutical Sciences 58 (5 …, 2003 | 52 | 2003 |
Complement activation by PEG-functionalized multi-walled carbon nanotubes is independent of PEG molecular mass and surface density. MSM ANDERSEN ALINA J,WINDSCHIEGL BARBARA,ILBASMIS TAMER SIBEL,DEGIM ISMAIL ... Nanomedicine 9 (4), 469 - 473, 2013 | 49* | 2013 |
Oral administration of liposomal insulin IT Değim, B Gümüşel, Z Değim, T Özçelikay, A Tay, Ş Güner Journal of Nanoscience and Nanotechnology 6 (9-10), 2945-2949, 2006 | 45 | 2006 |
Rectal and vaginal administration of insulin–chitosan formulations: An experimental study in rabbits Z Değim, T Değim, F Acartürk, D Erdoğan, C Özoğul, M Köksal Journal of drug targeting 13 (10), 563-572, 2005 | 45 | 2005 |
Transdermal administration of bromocriptine IT Degim, F Acartürk, D Erdogan, ND Lortlar Biological and Pharmaceutical Bulletin 26 (4), 501-505, 2003 | 45 | 2003 |
Stimuli-responsive lipid nanotubes in gel formulations for the delivery of doxorubicin S Ilbasmis-Tamer, H Unsal, F Tugcu-Demiroz, GD Kalaycioglu, IT Degim, ... Colloids and Surfaces B: Biointerfaces 143, 406-414, 2016 | 38 | 2016 |
Modern Farmasötik Teknoloji F Acartürk, İ Ağabeyoğlu, N Çelebi, T Değim, Z Değim, T Doğanay, ... Türk Eczacılar Birliği Yayını 1, 257-261, 2007 | 38 | 2007 |